Navigation Links
HPV Vaccine: Is Media Driving Reports of Side Effects?; polyDNA Recommends Gene-Eden-VIR, an HPV Remedy with No Side Effects
Date:12/6/2013

Rochester, NY (PRWEB) December 06, 2013

A study published in the Journal of Adolescent Health found a correlation between media coverage and the number of side effects reported on Gardasil (1). As the Center for Advancing Health reports, “The number of adverse events associated with the HPV vaccine reported to the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) appeared to be related to media coverage and online controversy about the vaccine (1).”

The study compared the number of people reporting side effects for the HPV vaccine, Gardasil, and Menactra, a vaccine to prevent meningitis. “The authors compared the amount of print media coverage that the two vaccines received during two and a half years following their FDA approval. The researchers also examined the association between adverse effects reported for each of the two vaccines and the amount of online search activity related to them (1).” They found a high correlation.

The researchers discovered that many more side effects were reported in connection to Gardasil than to Menactra. “During that time frame, the vaccine adverse event reporting system (VAERS) maintained by the CDC and FDA received a monthly average of 159 adverse reports for Gardasil versus 19 for Menactra. Print media coverage was much heavier for Gardasil, spiking in month nine with 147 media reports. During the preceding 8 months, there was no significant difference in adverse event reports for Gardasil and Menactra (1).” This means that more reports in the media regarding Gardasil translated into more people reporting side effects. It is interesting that the study does not speculate on the reason for this relationship.

“It is possible that the media is driving the increase in people complaining. However, it is also possible that at the same time there was an increase in the number of people who were vaccinated. In other words, another possible explanation is more media driving more vaccinations, which results in more side effects. We don’t know. However, we recommend Gene-Eden-VIR, a clinically proven HPV remedy with no reported side effects.” – Mike Evans, polyDNA

A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced HPV symptoms. Study authors wrote that, “Individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (2).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (2).”

To learn more about Gene-Eden-VIR, and HPV visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1)    Media Coverage of HPV Vaccine Boosts Reports of Adverse Effects. Published on November 19, 2013.
     http://www.cfah.org/hbns/2013/media-coverage-of-hpv-vaccine-boosts-reports-of-adverse-effects#.Up7y9NIW393

(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing
Clinical Study. Published on August 12, 2013.
     http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2013/12/prweb10541072.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Immune Cell Discovery May One Day Lead to Herpes Vaccine: Study
2. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
3. H1N1 discovery paves way for universal flu vaccine: UBC research
4. Mayo Clinic and Swedish Medical Center to Lead Webinar on Successful Ways to Use Social Media as Patient Engagement Tool
5. Computer model suggests genetic breast cancer screening may benefit those at intermediate risk
6. Generation Next Film/Television, Journalism and Social Media Competition Deadline Extended to December 13, 2013
7. Toll-like receptor 4-mediated apoptosis of hippocampal neurons
8. Marketing firm launches website to assist small professional service businesses with social media marketing programs.
9. Obesity, smoking increase risk after immediate breast reconstruction with implants
10. Ethnic identification helps Latina adolescents resist media barrage of body images
11. Eclectic Media Productions Restructuring While Company Expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... An ... permit amputees to safely ride all types of amusement park rides. , The patent-pending ... the unit is easy to use and could be set up in a matter ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pennsylvania Cable Network (PCN) during the summer of 2016. The program was made ... by the United States Department of Health and Human Services Administration. The ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate that ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... KEY FINDINGS North America ... market in 2016 and is expected to continue in ... a large number of surgical procedures that are taking ... in the patient temperature management market.) Patient warming and ... of blood during surgeries, lowering the risks of neurological ...
(Date:12/8/2016)... , Dec 8, 2016 Research and ... Market Analysis and Trends - Adhesion Type, Application, Usability - Forecast ... ... Global Cardiology Electrodes Market is poised to grow at a CAGR ... trends that the market is witnessing include advancements in extracellular microelectrode ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: